Prevention or inhibition of pathogenic syndromes caused by nitric oxide overproduction using iron-containing hemoprotein
US6103690A · kind A · utility
3Cited by
11References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 2, 1998 |
| Grant date | Aug 15, 2000 |
| Priority date | — |
| Expiry date | Dec 2, 2018 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to a method for the prophylaxis or treatment of an animal for deleterious physiological effects such as systemic hypotension caused by nitric oxide production induced by a biological response modifier. Examples of such biological response modifiers include but are not limited to a cytokine and an endotoxin. The invention is also directed to a method for the treatment of septic shock.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.